Scinopharm Taiwan Ltd. (1789)
TWSE
Closed
Oct 8, 2026
Day's Range
18.9052 wk Range
16.70Overview - 1789 - Scinopharm Taiwan Ltd.
Key Statistics
Valuation
Enterprise Value
12.08B
P/E (Trailing)
‪465.00‬
P/E (Forward)
‪46.50‬
PEG Ratio
‪-2.79‬
Price / Sales (TTM)
‪4.79‬
Price / Book
‪1.40‬
EV / EBITDA
‪28.16‬
Profitability
Gross Margin
‪19.84%‬
Profit Margin
‪1.23%‬
Operating Margin
‪-9.64%‬
Return on Assets
‪-0.35%‬
Return on Equity
‪0.36%‬
Ownership
Shares Outstanding
790.73M
Float
247.24M
Held by Insiders
‪58.51%‬
Held by Institutions
‪15.26%‬
Price stats
Beta
‪0.43‬
50-Day Avg
‪19.07‬
200-Day Avg
‪20.49‬
Dividends
Payout Ratio
‪651.40%‬
Frequency
Annual
Analyst Consensus
1 analysts
Market Cap - 1789 - Scinopharm Taiwan Ltd.
Peers - 1789 - Scinopharm Taiwan Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TWSE.
- 1789TWSEScinopharm Taiwan Ltd.14.70BMarket Cap-1.61%52-week change465.00P/E (Trailing)‪1.23%‬Profit Margin
- 1513TWSEChung-Hsin Electric & Machinery Manufacturing Corp.82.01BMarket Cap+7.53%52-week change18.65P/E (Trailing)‪15.73%‬Profit Margin
- 3030TWSETest Research Inc.63.77BMarket Cap+35.00%52-week change20.49P/E (Trailing)‪32.69%‬Profit Margin
- 1795TWSELotus Pharmaceutical Co., Ltd.46.69BMarket Cap-45.97%52-week change12.34P/E (Trailing)‪13.22%‬Profit Margin
- 4123TWSECenter Laboratories, Inc.23.35BMarket Cap-8.72%52-week change78.00P/E (Trailing)‪61.50%‬Profit Margin
- 6620TWSEHanda Pharmaceuticals, Inc.23.32BMarket Cap-3.14%52-week change46.59P/E (Trailing)‪40.48%‬Profit Margin
- 4105TWSETTY Biopharm Company Limited19.46BMarket Cap+0.77%52-week change11.25P/E (Trailing)‪26.04%‬Profit Margin
Profile Summary - 1789 - Scinopharm Taiwan Ltd.
About
Scinopharm Taiwan Ltd. operates as a specialized pharmaceutical company that focuses on the research, development, and manufacture of active pharmaceutical ingredients (APIs). Known for its strong emphasis on technological innovation and quality control, Scinopharm serves as a crucial entity in the global…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
